# The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer

> **NCT01531452** · PHASE2 · COMPLETED · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 43 (actual)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** s1

## Key facts

- **NCT ID:** NCT01531452
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-11
- **Final completion:** 2013-06
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2014-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01531452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01531452, "The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01531452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*